Olga Ivanov, MD, breast cancer surgeon at the Florida Hospital Cancer Institute, discusses sexual difficulties women who have had risk-reducing cancer surgery face.
Olga Ivanov, MD, breast cancer surgeon at the Florida Hospital Cancer Institute, discusses sexual difficulties women who have had risk-reducing cancer surgery face.
A survey of women with BRCA1 and BRCA2 mutations showed that 80%-90% of these survivors expressed concern about their sexual drive, after surgery sent them into early menopause. In fact, 40% of these women responded that they were sexually inactive.
Ivanov emphasizes the importance of patients and their healthcare teams discussing this possible side effect from risk-reducing surgery. There is a great need for patient education and the exploration of complementary medicines to manage low sex drive.
Workflow, Educational Tools Improve Use of Silicone Film to Prevent Radiation Dermatitis
April 25th 2024Tools to educate oncology nurses and patients on the use of Mepitel film to prevent radiation dermatitis has improved the workflow around its introduction to patients with breast cancer, as well as its application and maintenance.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.